Standard Biotools (LAB) Interest Coverage Ratio (QoQ) (2010 - 2026)
Standard Biotools (LAB) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.52 Bn | 193.92 Bn | 7.27 Bn |
| 2 | Stryker | 129.55 Bn | 126.07 Bn | 4.50 Bn |
| 3 | Medtronic | 119.60 Bn | 110.38 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.64 Bn | 73.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.33 Bn | 48.08 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.74 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.10 Bn | 31.99 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Standard Biotools | 254.35 Mn | -222.37 Mn | 10.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -244.16% |
| Mar 31, 2026 | 99.87% |
| Dec 31, 2025 | 31.98% |
| Sep 30, 2025 | -28.18% |
| Jun 30, 2025 | -34,105.50% |
| Mar 31, 2025 | 58.41% |
| Dec 31, 2024 | -3,013.53% |
| Sep 30, 2024 | 75.54% |
| Jun 30, 2024 | -99.96% |
| Mar 31, 2024 | 86.71% |
| Dec 31, 2023 | 24.96% |
| Sep 30, 2023 | 23.04% |
| Jun 30, 2023 | 22.13% |
| Mar 31, 2023 | 66.91% |
| Dec 31, 2022 | -120.88% |
| Sep 30, 2022 | 16.63% |
| Jun 30, 2022 | -53.60% |
| Sep 30, 2021 | 0.45% |
| Jun 30, 2021 | 5.79% |
| Mar 31, 2021 | 33.77% |